Pharmaceuticals
-
How At-Home Igalmi Differs From Traditional Treatments for Schizophrenia and Bipolar Agitation
Breaking down the FDA-approved sublingual film’s mechanism, trial statistics, and accessibility for patients managing acute agitation at home.
-
GSK to Nearly Double Cancer Drugs in Trials as It Rebuilds Oncology Ahead of HIV Patent Cliff
Amidst looming patent expirations for HIV blockbusters, GSK is aggressively expanding its oncology pipeline, aiming to double late-stage cancer drug studies by…
-
MK615 Apricot Extract: Lab Promise vs. Limited Human Trial Data
While viral clips claim MK615 kills 95% of cancer cells, a small Phase I trial showed only disease stabilization, not tumor shrinkage,…
-
Viatris Secures FDA Approval for RYZUMVI to Treat Presbyopia in Adults
Viatris wins FDA approval for RYZUMVI to treat presbyopia, adding a new option for aging eyes while seeking a U.S. commercial partner.
-
FDA Approves Zanvastro, the First Drug for the Rare Brain Disorder Alexander Disease
Madison, October 16 — The US Food and Drug Administration has approved Zanvastro, the first drug designed to directly treat Alexander disease,…
-
Manufacturing Site Issues Delay FDA Decision on Novo’s Once-Monthly Hemophilia A Drug Denecimig
Bagsværd, October 6 — Novo Nordisk confirmed on October 2 that the FDA review of its denecimig biologics license application remains delayed…
-
FDA Approved All Eight Rare Disease Decisions Due in September 2026, Six of Them Early
WASHINGTON, October 2 — The FDA’s October 2026 decision calendar is relatively light compared to previous months, with a limited number of…
-
New Alzheimer’s Drug Lecanemab Slows Cognitive Decline in Trial
WASHINGTON, July 14 — For the millions of American families watching a loved one slowly lose their memories, the arrival of lecanemab…
-
Only 43 Antibiotics in Development as WHO Warns the Pipeline Falls Short
SINGAPORE, July 11 — For communities across Asia, the medicines that treat common infections are something many families take for granted. But…
-
UCSF team reprograms T cells inside the body to clear cancer in mice
ISLAMABAD, July 10 — For patients and families facing blood cancers, the word “remission” carries a weight that is both fragile and…
-
Senolytics: Clearing Senescent Cells to Combat Age-Related Disease
ROCHESTER, Minnesota, July 8 — For a field that began with a single question about aging cells, senolytic research has come a…
-
Roche Launches Subcutaneous Lung Cancer Immunotherapy in India
MUMBAI — The needle goes in. Seven minutes later, it’s over. That is the new reality for lung cancer patients in India,…
-
Mazdutide Meets All Key Goals in Chinese Phase III Obesity Trial, Innovent Says
China, May 21, 2025 — infopulsetoday.com — New clinical data released in May 2025 show that the investigational drug mazdutide, a once-weekly…
-
FDA Approves Vertex’s Journavx, the First New Class of Pain Medicine in Over 20 Years
Vertex Pharmaceuticals is awaiting a regulatory decision on suzetrigine, a non-opioid analgesic designed for moderate to severe acute pain. The drug, which…
-
AHS Position Statement Makes CGRP Migraine Drugs a First-Line Preventive Option
America, March 12, 2024 — cyberinktimes.com — For millions of Americans who live with migraines, the standard advice has long been the…
-
How the GLP-1 Hormone Works and Why It Became a Diabetes and Obesity Drug Target
A hormone first characterized in the 1980s has become the foundation of a major transformation in how physicians manage diabetes and obesity.…
-
More Than 320 US Drugs Went Short in 2024, and Many Shortages Lasted Years
The scope of the 2024 drug shortage in the United States extends far beyond a simple inventory problem, now affecting over 300…
-
FDA Approves Lung Cancer Drug Augtyro for ROS1-Positive Tumors, Trial Shows Responses
The U.S. Food and Drug Administration granted approval on November 15, 2023, for Repotrectinib, marketed as Augtyro, to treat a defined group…
-
FDA Approves Adstiladrin, First Gene Therapy for BCG-Unresponsive Bladder Cancer
United States, December 20, 2022 — cybernewschronicle.com — Nadofaragene firadenovec, a gene therapy marketed under the brand name Adstiladrin, has been approved…
-
Takeda begins plasma therapy development for coronavirus patients
Takeda Initiates Development of Plasma-Derived Therapy for COVID-19 Treatment In a significant move, Takeda Pharmaceutical Company, Japan’s leading pharmaceutical firm, announced on…
-
FDA Reports First Coronavirus-Related Drug Shortage as China Supply Chain Strains
On March 5 2020, the rapid spread of the novel coronavirus in China forced the closure or reduced operation of factories in…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
New Studies Show Immunotherapy Gaining Ground in Lung, Prostate and Childhood Cancers
-
Why Broad RAS-Targeting Drugs Mark a Turning Point in Treating Pancreatic Cancer
-
How At-Home Igalmi Differs From Traditional Treatments for Schizophrenia and Bipolar Agitation
-
Boron Neutron Capture Therapy Faces US Coverage Hurdles Over Cost and Data Gaps
-
FDA Proposes Slashing Companion Diagnostic Fees From $636,732 to $28,653
-
Biocon’s Pebrilzo FDA Approval Cements Its Role in Affordable Cancer Care
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992





















